Related Experiment Video
Updated: Aug 8, 2026
06:50
A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
Published on: June 10, 2020
Decompressive craniectomy in traumatic brain injury: the randomized multicenter RESCUEicp study (www.RESCUEicp.com)
P J Hutchinson1, E Corteen, M Czosnyka
1Department of Neurosurgery, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. pjah2@cam.ac.uk
Acta Neurochirurgica. Supplement
|May 5, 2006
Summary
The RESCUEicp study investigates decompressive craniectomy for severe traumatic brain injury. This surgical procedure aims to reduce uncontrollable intracranial pressure when initial treatments fail.
Area of Science:
- Neurosurgery
- Trauma Care
- Critical Care Medicine
Background:
- Traumatic brain injury (TBI) can lead to elevated intracranial pressure (ICP).
- Uncontrolled ICP is a major cause of secondary brain damage and mortality in TBI patients.
- Standard medical management for refractory ICP has limitations.
Purpose of the Study:
- To evaluate the efficacy and safety of decompressive craniectomy in TBI patients with uncontrollable ICP.
- To determine if early surgical intervention improves outcomes compared to continued medical management.
- To provide evidence-based guidelines for the surgical management of severe TBI.
Main Methods:
- The RESCUEicp study is a randomized controlled trial.
- Patients with severe TBI and refractory ICP will be recruited.
- Participants will be randomized to either decompressive craniectomy or continued maximal medical therapy.
Main Results:
- Results are pending as the study is ongoing.
- The study aims to compare mortality and functional outcomes between treatment groups.
- Analysis will focus on ICP control, length of stay, and neurological recovery.
Conclusions:
- The findings of the RESCUEicp study will inform clinical practice for TBI management.
- Decompressive craniectomy may offer a survival or functional benefit in select TBI patients.
- Evidence from this trial is crucial for refining treatment protocols for severe TBI.
